Oligonucleotide Deprotection Solvent Selection

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current methods for removing ether-type protecting groups from the 2'-hydroxyl group of oligonucleic acid derivatives are not efficient under neutral conditions, requiring harsh chemicals and solvents, which can affect the reproducibility and yield of oligo-RNA production.

Innovation Solution

The use of sulfoxide-based or amide-based solvents, such as DMSO or DMF, in combination with TBAF, allows for the efficient removal of ether-type protecting groups from the 2'-hydroxyl group of oligonucleic acid derivatives under neutral conditions, improving reproducibility and yield in oligo-RNA synthesis.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If TBAF is used in traditional solvents for removing ether-type protecting groups, then the protecting group can be removed, but the reaction requires harsh conditions and shows poor reproducibility

Engineering Contradiction:
Improvereproducibility of deprotection reactionVSAvoidharsh reaction conditions
Core Design Contradiction:
ReliabilityVSObject-affected harmful factors

Solution Approach 1:

The patent changes the solvent parameter from traditional solvents (THF, dioxane) to sulfoxide-based solvents (DMSO, sultone) or amide-based solvents (DMF, NMP). This parameter change enables the deprotection reaction to proceed under milder, more reproducible conditions while maintaining high efficiency in removing the CEM protecting group from oligonucleotide 2'-hydroxyl groups

Inventive Principle:
Principle #35Parameter changes

2Productivity

If traditional solvents are used for deprotection, then the procedure is simple, but the efficiency and yield of oligo-RNA production are reduced

Engineering Contradiction:
Improveyield of oligo-RNA productionVSAvoidsimplicity of deprotection procedure
Core Design Contradiction:
ProductivityVSEase of manufacture

Solution Approach 1:

By changing the solvent parameter to sulfoxide-based or amide-based solvents, the patent achieves significantly improved deprotection efficiency and oligo-RNA yield. The procedure remains simple and straightforward, requiring only the substitution of the solvent type while maintaining ease of operation

Inventive Principle:
Principle #35Parameter changes

Solution Approach 2:

The patent employs a composite approach by combining TBAF (the deprotecting agent) with specific sulfoxide-based or amide-based solvents. This composite system enhances the overall deprotection efficiency and oligo-RNA production yield while keeping the procedure simple

Inventive Principle:
Principle #40Composite materials

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

This method enhances the efficiency and reproducibility of removing ether-type protecting groups, leading to higher purity and yield of oligo-RNA production with reduced environmental impact and operational costs.

Implementation Method 1

tetrabutylammonium fluoride (hereinafter referred to as 'TBAF') is generally used as a deprotecting agent

Methodology Applied
Scientific EffectFluorine-mediated deprotection:

Implementation Method 2

the present inventor has found that an oligonucleic acid derivative represented by the following general formula (11) can be efficiently produced by using a sulfoxide-based solvent or an amide-based solvent or a mixture thereof

Methodology Applied
Scientific EffectSolvation effect: Solvation

Data Source

PatentEP1995253B1Method for detaching protecting group on nucleic acid
Publication Date: 2016.12.21 NIPPON SHINYAKU CO LTD
  • EP1995253B1 patent drawing
  • EP1995253B1 patent drawing
  • EP1995253B1 patent drawing

AI summary

The main object of the present invention is to provide a method for removing a 2-cyanoethoxymethyl (CEM) group, which substitutes the 2'-hydroxyl group of each ribose of an oligonucleic acid derivative, with good reproducibility and high efficiency. The object is to provide a method for producing an oligonucleic acid derivative represented by the following general formula (11), characterized by using a sulfoxide-based solvent or an amide-based solvent or a mixture thereofas a reaction solvent in the step of removing a protecting group, which protects the 2'-hydroxyl group of each ribose of an oligonucleic acid derivative represented by the following general formula (10) by allowing TBAF to act on the oligonucleic acid derivative.